Acute Nicotine Gum and Tinnitus Loudness in Non-Smoking Adults
Key facts
- Who runs it
- San Diego State University
- Where
- San Diego, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 1/2
- People taking part
- 29 people enrolled
- Started
- 25 Mar 2026
- Ended
- 3 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Nicotine polacrilex gum 4 mg
- Placebo gum
- Record updated
- 16 October 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Non-smoking adult, defined as fewer than 100 cigarettes in a lifetime and none in the past year, with a Fagerstrom Test for Nicotine Dependence score of 2 or less and a negative urinary cotinine test
- Chronic subjective tinnitus of at least 6 months' duration
Who cannot take part
- Unstable cardiovascular disease
- Any condition precluding the psychoacoustic tasks
- Current or recent tobacco or nicotine use
- Pregnancy or breastfeeding
Where in United States
- San Diego State UniversitySan Diego, United States
About the trial
What the trial wants to find out
This study tested whether a single dose of nicotine gum can reduce the loudness of tinnitus (ringing in the ears) in non-smoking adults with chronic tinnitus. Nicotine acts on brain nicotinic acetylcholine receptors that regulate the balance of excitation and inhibition in auditory and attention networks, and may temporarily quiet the phantom sound while improving the ability to focus on relevant sounds. Using a double-blind, placebo-controlled, within-subject crossover design, each participant attended two sessions and received a single 4 mg dose of nicotine polacrilex gum at one session and a flavor-matched placebo gum at the other, in random order. The primary measure was the within-session change in a psychoacoustic match of tinnitus loudness; auditory selective attention was a secondary measure.
The 2 groups in the trial
- Nicotine gum (4 mg)Treatment being tested
Single 4 mg dose of nicotine polacrilex gum, chewed for 20 minutes at 1 Hz using the standardized administration protocol.
Treatment: Nicotine polacrilex gum 4 mg
- Placebo gumPlacebo, for comparison
Flavor-, color-, shape-, and texture-matched placebo gum, chewed under the identical protocol.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Double-Blind, Placebo-Controlled, Within-Subject Crossover Trial of a Single 4 mg Dose of Nicotine Polacrilex Gum on Psychoacoustic Tinnitus Loudness and Selective Attention in Non-Smoking Adults With Chronic Subjective Tinnitus
- Record updated
- 16 October 2026